Morgan Stanley Cuts Eli Lilly: Says Downgraded Not Related to Negative Call on Alzheimer's Data, Sees Current Share Price Factoring 'in pipelineenthusiasm for two blockbuster candidates:' Solanezumab, Evacetrapib